1213 related articles for article (PubMed ID: 15262412)
21. Dodecaborate lipid liposomes as new vehicles for boron delivery system of neutron capture therapy.
Ueno M; Ban HS; Nakai K; Inomata R; Kaneda Y; Matsumura A; Nakamura H
Bioorg Med Chem; 2010 May; 18(9):3059-65. PubMed ID: 20371186
[TBL] [Abstract][Full Text] [Related]
22. Liposomal boron delivery for neutron capture therapy.
Nakamura H
Methods Enzymol; 2009; 465():179-208. PubMed ID: 19913168
[TBL] [Abstract][Full Text] [Related]
23. Biodistribution of BPA and BSH after single, repeated and simultaneous administrations for neutron-capture therapy of cancer.
Ichikawa H; Taniguchi E; Fujimoto T; Fukumori Y
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S111-4. PubMed ID: 19376721
[TBL] [Abstract][Full Text] [Related]
24. Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of sodium borocaptate with or without blood-brain barrier disruption.
Yang W; Barth RF; Rotaru JH; Moeschberger ML; Joel DD; Nawrocky MM; Goodman JH; Soloway AH
Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):663-72. PubMed ID: 9112465
[TBL] [Abstract][Full Text] [Related]
25. Factors governing the in vivo tissue uptake of transferrin-coupled polyethylene glycol liposomes in vivo.
Hatakeyama H; Akita H; Maruyama K; Suhara T; Harashima H
Int J Pharm; 2004 Aug; 281(1-2):25-33. PubMed ID: 15288340
[TBL] [Abstract][Full Text] [Related]
26. Effect of electroporation on cell killing by boron neutron capture therapy using borocaptate sodium (10B-BSH).
Ono K; Kinashi Y; Masunaga S; Suzuki M; Takagaki M
Jpn J Cancer Res; 1998 Dec; 89(12):1352-7. PubMed ID: 10081497
[TBL] [Abstract][Full Text] [Related]
27. Targeted delivery of doxorubicin using stealth liposomes modified with transferrin.
Li X; Ding L; Xu Y; Wang Y; Ping Q
Int J Pharm; 2009 May; 373(1-2):116-23. PubMed ID: 19429296
[TBL] [Abstract][Full Text] [Related]
28. Accumulation of boron compounds to tumor with polyethylene-glycol binding liposome by using neutron capture autoradiography.
Yanagië H; Ogura K; Takagi K; Maruyama K; Matsumoto T; Sakurai Y; Skvarc J; Illic R; Kuhne G; Hisa T; Yoshizaki I; Kono K; Furuya Y; Sugiyama H; Kobayashi H; Ono K; Nakagawa K; Eriguchi M
Appl Radiat Isot; 2004 Oct; 61(4):639-46. PubMed ID: 15246411
[TBL] [Abstract][Full Text] [Related]
29. Boron microlocalization in oral mucosal tissue: implications for boron neutron capture therapy.
Morris GM; Smith DR; Patel H; Chandra S; Morrison GH; Hopewell JW; Rezvani M; Micca PL; Coderre JA
Br J Cancer; 2000 Jun; 82(11):1764-71. PubMed ID: 10839288
[TBL] [Abstract][Full Text] [Related]
30. Accumulation of 10B in the central degenerative areas of human glioma and colon carcinoma spheroids after sulfhydryl boron hydride administration.
Pettersson OA; Carlsson J; Grusell E
Cancer Res; 1992 Mar; 52(6):1587-91. PubMed ID: 1540968
[TBL] [Abstract][Full Text] [Related]
31. Dosimetric study of boron neutron capture therapy with borocaptate sodium (BSH)/lipiodol emulsion (BSH/lipiodol-BNCT) for treatment of multiple liver tumors.
Suzuki M; Sakurai Y; Masunaga S; Kinashi Y; Nagata K; Ono K
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):892-6. PubMed ID: 14967447
[TBL] [Abstract][Full Text] [Related]
32. Cationized gelatin-HVJ envelope with sodium borocaptate improved the BNCT efficacy for liver tumors in vivo.
Fujii H; Matsuyama A; Komoda H; Sasai M; Suzuki M; Asano T; Doki Y; Kirihata M; Ono K; Tabata Y; Kaneda Y; Sawa Y; Lee CM
Radiat Oncol; 2011 Jan; 6():8. PubMed ID: 21247507
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and biological evaluation of folate receptor-targeted boronated PAMAM dendrimers as potential agents for neutron capture therapy.
Shukla S; Wu G; Chatterjee M; Yang W; Sekido M; Diop LA; Müller R; Sudimack JJ; Lee RJ; Barth RF; Tjarks W
Bioconjug Chem; 2003; 14(1):158-67. PubMed ID: 12526705
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of sodium mercaptoundecahydrododecaborate after intravenous injection in rats.
Mehta SC; Boudinot FD; Lu DR
Drug Metab Dispos; 1995 Dec; 23(12):1368-71. PubMed ID: 8689945
[TBL] [Abstract][Full Text] [Related]
35. EGF-receptor targeted liposomes with boronated acridine: growth inhibition of cultured glioma cells after neutron irradiation.
Kullberg EB; Wei Q; Capala J; Giusti V; Malmström PU; Gedda L
Int J Radiat Biol; 2005 Aug; 81(8):621-9. PubMed ID: 16298943
[TBL] [Abstract][Full Text] [Related]
36. The radiation biology of boron neutron capture therapy.
Coderre JA; Morris GM
Radiat Res; 1999 Jan; 151(1):1-18. PubMed ID: 9973079
[TBL] [Abstract][Full Text] [Related]
37. Combined use of sodium borocaptate and buthionine sulfoximine in boron neutron capture therapy enhanced tissue boron uptake and delayed tumor growth in a rat subcutaneous tumor model.
Yoshida F; Yamamoto T; Nakai K; Kumada H; Shibata Y; Tsuruta W; Endo K; Tsurubuchi T; Matsumura A
Cancer Lett; 2008 May; 263(2):253-8. PubMed ID: 18272285
[TBL] [Abstract][Full Text] [Related]
38. Boron neutron capture therapy of brain tumors: enhanced survival and cure following blood-brain barrier disruption and intracarotid injection of sodium borocaptate and boronophenylalanine.
Barth RF; Yang W; Rotaru JH; Moeschberger ML; Boesel CP; Soloway AH; Joel DD; Nawrocky MM; Ono K; Goodman JH
Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):209-18. PubMed ID: 10758326
[TBL] [Abstract][Full Text] [Related]
39. Electroporation increases the effect of borocaptate (10B-BSH) in neutron capture therapy.
Ono K; Kinashi Y; Masunaga S; Suzuki M; Takagaki M
Int J Radiat Oncol Biol Phys; 1998 Nov; 42(4):823-6. PubMed ID: 9845104
[TBL] [Abstract][Full Text] [Related]
40. Delivery of sodium borocaptate to glioma cells using immunoliposome conjugated with anti-EGFR antibodies by ZZ-His.
Feng B; Tomizawa K; Michiue H; Miyatake S; Han XJ; Fujimura A; Seno M; Kirihata M; Matsui H
Biomaterials; 2009 Mar; 30(9):1746-55. PubMed ID: 19121537
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]